Susana Ros
University of Cambridge
H-index: 21
Europe-United Kingdom
Top articles of Susana Ros
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer | British Journal of Cancer | Cath Eberlein Stuart C Williamson Lorna Hopcroft Susana Ros Jennifer I Moss | 2024/2/23 |
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation | Science Signaling | Emily C Erickson Inchul You Grace Perry Aurelien Dugourd Katherine A Donovan | 2024/2/27 |
Neuro-Oncology Advances | Masafumi Miyai Tomohiro Kanayama Fuminori Hyodo Takamasa Kinoshita Takuma Ishihara | 2020 | |
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models | NPJ breast cancer | Lorna Hopcroft Eleanor M Wigmore Stuart C Williamson Susana Ros Cath Eberlein | 2023 |
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and … | Cancer Research | Mandy Lawson Natalie Cureton Susana Ros Azadeh Cheraghchi-Bashi Jelena Urosevic | 2023/12/1 |
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models | NPJ Breast Cancer | Lorna Hopcroft Eleanor M Wigmore Stuart C Williamson Susana Ros Cath Eberlein | 2023/8/5 |
Abstract P3-07-13: The next generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) is active against wild type and mutant estrogen receptor α | Christopher Morrow Larissa Carnevalli Richard D Baird Tim Brier Carmela Ciardullo | 2023/3/1 | |
Abstract PD10-04: PD10-04 Combination of the next generation oral SERD camizestrant (AZD9833) with CDK4/6 and mTOR/AKT inhibitors delivers robust efficacy in a broad range of … | Cancer Research | Larissa Carnevalli Susana Ros Jelena Urosevic Natalie Cureton Sophie Darcy | 2023/3/1 |
Characterization of full-length p53 aggregates and their kinetics of formation | Biophysical Journal | Linda Julian Jason C Sang Yunzhao Wu Georg Meisl Jack H Brelstaff | 2022/11/15 |
Increased BCAT1 expression creates a pseudo-hypoxic environment that promotes cell proliferation in a subtype of glioblastoma | Cancer Research | Maria Fala Susana Ros Ashley Sawle Kevin M Brindle | 2022/6/15 |
Metabolic heterogeneity in breast cancer integrative clusters to screen metabolic vulnerabilities for diagnosis and treatment response | Cancer Research | Susana Ros Alan J Wright Flaviu Bulat Wendy Greenwood De-en Hu | 2021/7/1 |
Metabolic imaging with hyperpolarized [1-13C] pyruvate in patient-derived preclinical mouse models of breast cancer | STAR protocols | Susana Ros Alan J Wright Alejandra Bruna Carlos Caldas Kevin M Brindle | 2021/9/17 |
18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography | Friederike Hesse De-En Hu Susana Ros Willmington-Holmes Connor Bangwen Xie | 2020/12/9 | |
18F-C2Am data | Flaviu Bulat Friederike Hesse De-En Hu Susana Ros Connor Willmington-Holmes | 2020/12/1 | |
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer | Cancer Cell | Susana Ros Alan J Wright Paula D'Santos De-en Hu Richard L Hesketh | 2020/10/12 |
Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells | Science signaling | Valentí Gómez Thomas R Eykyn Rami Mustapha Fabián Flores-Borja Victoria Male | 2020/10/6 |
